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Abstract
Low density lipoprotein receptor-related protein 2 gene (LRP2) is located next to the genomic region showing suggestive
linkage with both hip and wrist bone mineral density (BMD) phenotypes. LRP2 knockout mice showed severe vitamin D
deficiency and bone disease, indicating the involvement of LRP2 in the preservation of vitamin D metabolites and delivery of
the precursor to the kidney for the generation of 1a,25(OH)2D3. In order to investigate the contribution of LRP2 gene
polymorphisms to the variation of BMD in Chinese population, a total of 330 Chinese female-offspring nuclear families with
1088 individuals and 400 Chinese male-offspring nuclear families with 1215 individuals were genotyped at six tagSNPs of
the LRP2 gene (rs2389557, rs2544381, rs7600336, rs10210408, rs2075252 and rs4667591). BMD values at the lumbar spine 1–
4 (L1-4) and hip sites were measured by DXA. The association between LRP2 polymorphisms and BMD phenotypes was
assessed by quantitative transmission disequilibrium tests (QTDTs) in female- and male-offspring nuclear families separately.
In the female-offspring nuclear families, rs2075252 and haplotype GA of rs4667591 and rs2075252 were identified in the
nominally significant total association with peak BMD at L1-4; however, no significant within-family association was found
between peak BMD at the L1-4 and hip sites and six tagSNPs or haplotypes. In male-offspring nuclear families, neither the
six tagSNPs nor the haplotypes was in total association or within-family association with the peak BMD variation at the L1-4
and hip sites by QTDT analysis. Our findings suggested that the polymorphisms of LRP2 gene is not a major factor that
contributes to the peak BMD variation in Chinese population.
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Introduction
Osteoporosis is a complex disorder with multiple interactions
between genetic effects and environmental factors. The heritability of
bone mineral density (BMD) is 50–80% [1]. In numerous studies on
the genetic mechanisms of osteoporosis, associations between genes
involved in vitamin D metabolism and the variation of BMD have
been extensively reported [2,3,4,5]. According to genome-wide
association studies (GWAS) from the past two years, the highlighted
candidatedisease-causing genesofosteoporosis, amember ofthe Wnt
signaling pathway, binds to a membrane receptor complex
comprising a frizzled (FZD) G-protein-coupled receptor and a low
density lipoprotein receptor-related protein (LRP) [6].
The low density lipoprotein receptor-related protein 2 (LRP2) gene, also
termed glycoprotein-330 or megalin, is located on chromosome
2q24–q31 and was first reported by Farquhar and colleagues in
1995 [7]. This chromosome region is closely next to the 2q32, the
genomic region showing suggestive linkage with both hip and wrist
BMD phenotypes[8]. LRP2 knockout mice showed severe vitamin
D deficiency and bone disease [9], indicating the involvement of
LRP2 in the preservation of vitamin D metabolites and delivery of
the precursor to the kidney for the generation of 1a,25(OH)2D3.I n
2007, Hsu and colleague [10] firstly suggested that LRP2 is one of
two potential osteoporosis candidate genes in chromosome 2q
quantitative trait loci (QTL) region in a Chinese population.
There is no evidence, however, that LRP2 is a member of the LRP
family that is involved in the Wnt signaling pathway. The
association between LRP2 and peak BMD variation remains
unknown. The aim of this study was to investigate the contribution
of LPR2 gene polymorphisms to peak BMD variation in Chinese
female- and male-offspring nuclear families.
Results
Basic characteristics of study subjects
Two groups of subjects, 330 female-offspring nuclear families
and 400 male-offspring nuclear families, were involved in this
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unrestricted  use,  distribution,  and  reproduction  in  any  medium,  provided  the  original  author  and  source  are  credited.study. The detailed basic characteristics of these subjects are
summarized in Table 1. The average family size of female- and
male-offspring nuclear families were 3.3 (from 3 to 6) and 3.03
(from 3 to 4), respectively.
Genotype frequencies and linkage disequilibrium
All subjects were genotyped at six chosen tagSNPs. The MAF of
each tagSNP was agreed with the HapMap data of Chinese
population. The distribution of each genotype is in Hardy-
Weinberg equilibrium.
Three haplotype blocks were defined according to the LD value
in both female- and male-offspring nuclear families. In female-
offspring nuclear families, the LD pattern of block 1–3 are shown
in Figure 1a. The highest LD value of 0.78 was observed between
rs2544381 and rs2389557. In male-offspring nuclear families, the
LD pattern of block 1–3 are shown in Figure 1b. The highest LD
value of 0.86 was observed between rs4667591 and rs2075252.
Peak BMD phenotypes and genotypes in 330 unrelated
adult daughters and 400 unrelated adult sons from the
studied nuclear families
The peak BMD values at the L1-4 and hip sites and the
genotypes of the six tagSNPs are listed in Table 2. The reported
BMD values (mean6SD) were previously adjusted by age, height
and weight as covariates. There was no significant association
between genotypes and peak BMD phenotypes using GLM-
ANOVA.
Association between SNPs and haplotypes with peak
BMD variation in female- and male-offspring nuclear
families
The association between peak BMD and six tagSNPs or three
haplotype blocks in the LRP2 gene using QTDT analysis are
summarized in Table 3 and 4. There were 271, 236, 266, 271, 263
and 253 informative female-offspring nuclear families and 307,
238, 310, 310, 279 and 238 informative male-offspring nuclear
families for the QTDT analysis at rs2389557, rs2544381,
rs7600336, rs10210408, rs2075252 and rs4667591, respectively.
No population stratification was found for the six tagSNPs and
haplotypes in the study subjects.
In female-offspring nuclear families, rs2075252 and haplotype
GA of rs4667591 and rs2075252 were identified in nominally
significant total association with peak BMD at L1-4 (p=0.040 and
0.021, respectively). However, neither SNPs nor haplotypes was
found in the significant within-family association with peak BMD
at the L1-4 and hip sites in the same group.
In male-offspring nuclear families, for the total and within-
family associations, six tagSNPs were associated with neither the
variation of the L1-4 BMD nor the hip BMD (femoral neck and
total hip). Haplotype analysis revealed similar negative results. No
significant total association or within-family association was found
between any of the haplotypes in three blocks and the variations of
peak BMD at the L1-4 and hip sites.
Discussion
Although osteoporosis mainly occurs in the senior population,
this disease is largely determined by the peak bone mass that is
achieved in adulthood. In Chinese men and women, peak BMD at
the lumbar spine and hip sites is attained between the ages of 20
and 39 years [11,12]. Peak BMD is strongly controlled by genetic
determinants. The heritability estimates in our male-offspring,
calculated by parent-offspring regression [2,11], for peak BMD at
the lumbar spine, femoral neck and total hip were 0.565, 0.702
and 0.693, respectively. In our female-offspring, the heritability
estimates for peak BMD at the lumbar spine, femoral neck and
total hip were 0.545, 0.504 and 0.501, respectively.
Many association studies have been performed to discover the
genetic determinants of BMD. Estrogen receptor 1(ESR1),
ZBTB40, Tumor necrosis factor receptor superfamily 11B
(TNFRSF11B), Low density lipoprotein receptor-related protein
5 (LRP5), SP7, Tumor necrosis factor superfamily 11(TNFSF11)
and Tumor necrosis factor superfamily 11A (TNFSF11A) are
seven known loci associated with BMD at the GWAS level. The
knowledge with respect to the contribution of these seven loci to
the variation of BMD, however, is still limited [13,14,15]. To date,
the major genetic factors that influence BMD are unknown. Many
studies have suggested that BMD may influenced by numerous
minor genetic markers [16,17]. 1a,25(OH)2D3, which is the active
form of vitamin D, plays an important role in bone metabolism,
including bone mineralization, modeling and remodeling, by
regulating osteoblast and osteoclast functions [18,19]. A deficiency
of 1a,25(OH)2D3 may result in osteoporosis, fragility fractures and
other health problems [20,21]. Currently, extensive studies on the
vitamin D receptor gene (VDR) as an osteoporosis candidate gene
have yielded many contradictory results [2,22,23,24,25,26,27,28].
Recently, Lou and colleagues [29] reported that 25OHD3 acts as
an agonist of the vitamin D receptor ligand and has a synergistic
effect with 1a,25(OH)2D3 and that high expression of the LRP2
gene was found in Cyp27b1 gene knockout cells. Because the
Cyp27b1 gene encodes 1a-hydroxylase, which is necessary for the
activation of 25OHD3, this group suggested that 25OHD3 is not
only a prehormone of 1a,25(OH)2D3 but also plays a role in cell
proliferation and gene regulation.




















female-offspring nuclear families Father 330 63.267.6 166.866.1 70.0610.1 25.163.2 1.13960.182 0.88660.122 0.95860.126
Mother 330 60.567.1 155.465.6 59.369.0 24.663.5 0.98560.166 0.79060.126 0.84960.13
Daughter 428 34.566.9 159.865.1 55.667.7 21.862.9 1.17460.134 0.93660.114 0.96960.116
male-offspring nuclear families Father 400 61.167.1 167.866.0 69.769.5 25.262.7 1.13960.171 0.89260.132 0.95860.138
Mother 400 58.466.3 155.765.5 58.268.2 24.063.1 0.99260.168 0.79660.144 0.85260.162
Son 415 30.466.1 172.965.9 70.7610.8 24.263.2 1.13860.137 0.99560.141 1.00860.142
*The reported BMD values (mean6SD) are unadjusted raw BMD values.
doi:10.1371/journal.pone.0028874.t001
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PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28874The LRP2 gene is known as a virulence gene in Heymann
nephritis [30]. In 1999, Nykjaer and colleagues [9] first reported
that compounds of 25OHD3 and the vitamin D-binding protein
(DBP) were filtered through the glomerulus and reabsorbed by
LRP2 into the proximal tubular cells in animal studies. In LRP2
knockout mice, vitamin D deficiency and bone disease were
Figure 1. Haplotype linkage disequilibrium (LD) blocks in 330 female-offspring nuclear families and 400 male-offspring nuclear
families. Three LD blocks connecting SNP pairs are shaded based on the LD strength between SNPs by using the disequilibrium coefficient r
2, darker
shades of red indicate higher value of D’, up to maximum of 1. Figure 1a shows the LD pattern in the LRP2 gene based on the parents genotypes from
330 female-offspring nuclear families (n=660), while figure 1b presents the LD pattern from 400 male-offspring nuclear families (n=800).
doi:10.1371/journal.pone.0028874.g001

























rs2389557 TT 92 1.18360.012 0.94460.010 0.97260.010 120 1.13960.012 0.99860.012 1.01760.012
CC 66 1.18660.014 0.93160.012 0.96860.012 94 1.16960.013 1.01860.013 1.03060.013
CT 172 1.16460.009 0.93460.007 0.96860.007 186 1.12660.010 0.98760.009 1.00660.009
rs2544381 GG 186 1.17360.008 0.93560.007 0.96560.007 226 1.13560.009 0.99360.008 1.01060.008
CC 14 1.21260.031 0.93260.026 0.9860.026 26 1.13360.026 0.99360.025 1.01460.024
GC 130 1.17060.010 0.93960.008 0.97560.008 148 1.15060.011 1.00660.011 1.02360.010
rs7600336 CC 88 1.17160.012 0.92960.010 0.96860.010 118 1.14060.012 0.99460.012 1.10360.012
TT 55 1.18760.016 0.92960.013 0.96560.013 72 1.14260.016 1.00060.015 1.01960.015
CT 187 1.17160.008 0.94260.007 0.97260.007 210 1.14060.009 0.99960.009 1.01560.009
rs10210408 TT 55 1.17560.015 0.94160.013 0.97660.013 56 1.15760.018 0.99460.017 1.01260.017
CC 116 1.18560.011 0.93660.009 0.97260.009 133 1.14260.011 0.99860.011 1.01960.011
CT 159 1.16560.009 0.93560.008 0.96560.008 211 1.13560.009 0.99860.009 1.01460.009
rs2075252 AA 90 1.18860.012 0.93760.010 0.97460.010 135 1.14460.011 0.99960.011 1.01960.011
GG 63 1.14660.014 0.93360.012 0.95660.012 65 1.15460.016 1.01460.016 1.02560.015
AG 177 1.17660.009 0.93760.007 0.97160.007 200 1.13460.009 0.99260.009 1.01060.009
rs4667591 TT 101 1.16360.012 0.93160.010 0.95960.010 157 1.14160.011 0.99960.010 1.01960.010
GG 67 1.18860.014 0.93760.011 0.97660.011 54 1.15160.019 0.99160.018 0.99460.018
TG 162 1.17460.009 0.93960.007 0.97360.007 189 1.13760.010 0.99760.009 1.01360.009
doi:10.1371/journal.pone.0028874.t002
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Therefore, a renal uptake pathway that is essential for the
preservation of vitamin D metabolites and the delivery of the
precursor for the generation of 1a,25(OH)2D3 was defined. The
above-mentioned studies suggested that the LRP2 gene is involved
in the achievement and maintenance of peak BMD through the
function of 25OHD3.
To the best of our knowledge, this is the first study to investigate
the association between LRP2 gene polymorphisms and peak
BMD variation in female- and male-offspring nuclear families. Six
tagSNPs of the LRP2 gene were identified in 330 female-offspring
nuclear families with 1088 individuals and 400 male-offspring
nuclear families with 1215 individuals. The distribution frequen-
cies of these SNPs were in agreement with data from HapMap
Asian populations. BMD values at the L1-4 and hip sites were
measured individually as the phenotypes.
In female-offspring nuclear families, rs2075252 and haplotype
GA of rs4667591 and rs2075252 were identified in nominally
significant total association with peak BMD at lumbar spine.
Unfortunately, no within-family association between peak BMD
variation and SNPs or haplotypes was found in the same group. In
male-offspring nuclear families, neither the six tagSNPs nor the
haplotypes was in total association or within-family association
with the peak BMD variation at the L1-4 and hip sites by QTDT
analysis. The statistical power was estimated by the Piface
program (version 1.65 http://www.math.uiowa.edu/,rlenth/
Power/) at the time that this study was designed. In our previous
association studies of 401 female-offspring nuclear families with
1260 subjects and candidate genes (Estrogen receptor alpha and
Myostatin), the sample size offered more than 80% power and
explained about 10% of the BMD variation [31,32]. Based on the
MAF of each SNP in this study, 330 female-offspring nuclear
families with 1088 individuals and 400 male-offspring nuclear
families with 1215 subjects had sufficient power to detect any
association between the peak BMD and SNPs or haplotype blocks
and in Chinese population. Furthermore, five of the studied
tagSNPs had a MAF that was very close to or higher than 40%.
With greater heterozygosity, more information can be derived
from families by QTDT analysis.
To avoid false-positive results, two kinds of statistical analysis
were employed in the current study. QTDT analysis examines the
transmission of alleles from parents to offspring. Unlike ANOVA
analysis, which can be affected by population stratification, the
QTDT analysis eliminates this stratification. The within-family
association test of QTDT can also eliminate the effect of an
admixed and stratified population. Therefore, this analysis is more
powerful than ANOVA analysis. Moreover, haplotype analysis is
generally thought to be more powerful than analyses that employ
single markers. The total and within-family associations were also
tested between three haplotype blocks and BMD by QTDT in the
nuclear families. Thus, the results of this study should be reliable.
In summary, neither the six tagSNP polymorphisms nor the
three haplotype blocks of the LRP2 gene were associated with peak
BMD variation in either male or female Chinese population. This
Table 3. P values obtained for analyses of population stratification, total association and within-family association for six tagSNPs.
rs2389557 rs2544381 rs7600336 rs10210408 rs2075252 rs4667591
Test of population stratification in female-offspring nuclear families
L1-4 0.768 0.458 0.112 0.354 0.796 0.416
Femoral neck 0.327 0.931 0.648 0.550 0.898 0.545
Total hip 0.982 0.258 0.685 0.379 0.637 0.293
Test of total association in female-offspring nuclear families
L1-4 0.333 0.086 0.188 0.575 0.040* 0.154
Femoral neck 0.228 0.363 0.868 0.987 0.690 0.186
Total hip 0.462 0.796 0.907 0.936 0.172 0.099
Test of within-family association in female-offspring nuclear families
L1-4 0.390 0.103 0.720 0.286 0.136 0.083
Femoral neck 0.993 0.544 0.645 0.652 0.890 0.217
Total hip 0.623 0.291 0.700 0.539 0.631 0.070
Test of population stratification in male-offspring nuclear families
L1-4 0.491 0.860 0.127 0.275 0.351 0.408
Femoral neck 0.277 0.765 0.659 0.332 0.545 0.235
Total hip 0.292 0.433 0.887 0.837 0.915 0.753
Test of total association in male-offspring nuclear families
L1-4 0.593 0.649 0.796 0.804 0.737 0.647
Femoral neck 0.878 0.892 0.751 0.578 0.933 0.904
Total hip 0.603 0.914 0.385 0.267 0.603 0.456
Test of within-family association in male-offspring nuclear families
L1-4 0.753 0.949 0.146 0.407 0.492 0.566
Femoral neck 0.387 0.741 0.589 0.264 0.610 0.296
Total hip 0.526 0.461 0.578 0.715 0.748 0.558
*p,0.05.
doi:10.1371/journal.pone.0028874.t003
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This study was approved by the Ethics Committee of Shanghai
Sixth People’s Hospital, affiliated with Shanghai Jiaotong
University. All subjects involved in the study were recruited by
the Department of Osteoporosis and Bone Diseases from a
community center in Shanghai from 2004 to 2010. Two groups of
subjects were recruited, and the inclusive and exclusive criteria
were described previously [2,11]. Briefly, 330 female-offspring
nuclear families with 1088 individuals and 400 male-offspring
nuclear families with 1215 individuals were included in the study.
Each nuclear family has at least one healthy daughter or son aged
from 20 to 40 years old. All recruited daughters were
premenopausal. The exclusion criteria for the study subjects were
a history of: (1) serious residual effects of cerebral vascular disease;
(2) diabetes mellitus except for easily controlled type 2 diabetes
mellitus (defined as adult asymptomatic hyperglycemia controlled
by diet or oral agents); (3) chronic renal disease (serum creatinine
$11.9 mg/dl); (4) chronic liver disease; (5) chronic lung disease; (6)
corticosteroid therapy at pharmacologic levels for at least 12
weeks; (7) anticonvulsant therapy for at least 16 months; (8)
evidence of other metabolic or inherited bone diseases (eg, hyper-
or hypoparathyroidism, Paget’s disease, osteomalacia or osteogen-
esis imperfecta); (9) rheumatoid arthritis or collagen disease; (10)
major gastrointestinal disease (eg, peptic ulcer, malabsorption,
chronic ulcerative colitis, regional enteritis, or any signifcant
chronic diarrhea state); (11) signifcant disease of any endocrine
organ that would affect bone mass (eg, hyperthyroidism, etc); (12)
any neurologic or musculoskeletal condition that would be a
nongenetic cause of low bone mass; (13) menopause before 40
years old and (14) any disease, treatment or condition that would
be a nongenetic cause of low bone mass. After signing an informed
consent form, information on medical history, family history,
physical activity, developmental history, childbearing history,
alcohol use, smoking history and dietary habits including calcium
intake were collected by questionnaire.
BMD measurement
BMD of the anteroposterior lumbar spine 1–4 (L1-4) and left
proximal femur, including the femoral neck and total hip, were
measured using a lunar prodigy dual energy X-ray absorptiometry
(DXA) densitometer (GE Healthcare, Madison, WI, USA). The
data were analyzed using Prodigy enCORE software (ver. 6.70,
standard-array mode; GE Healthcare, Madison, WI, USA). The
machine was calibrated daily, and the coefficient of variability
(CV) values of the DXA measurements (obtained from triplicate
Table 4. P values obtained for analyses of population stratification, total association and within-family association for four
haplotypes of block 1–3.
Block 1 Block 2 Block 3
TA GG TG GA CC TT CT TC GT GC CC CT
Test of population stratification in female-offspring nuclear families
L1-4 0.451 0.117 0.972 0.603 0.144 0.717 0.348 0.303 0.204 0.295 0.343 0.827
Femoral neck 0.342 0.382 0.202 0.956 0.672 0.634 0.846 0.106 0.303 0.261 0.575 0.103
Total hip 0.745 0.113 0.393 0.521 0.615 0.413 0.653 0.301 0.525 0.520 0.647 0.409
Test of total association in female-offspring nuclear families
L1-4 0.423 0.524 0.262 0.021* 0.812 0.078 0.555 0.445 0.357 0.156 0.072 0.443
Femoral neck 0.389 0.434 0.987 0.194 0.945 0.896 0.942 0.607 0.406 0.603 0.651 0.325
Total hip 0.682 0.375 0.921 0.503 0.678 0.231 0.833 0.819 0.271 0.945 0.808 0.839
Test of within-family association in female-offspring nuclear families
L1-4 0.272 0.403 0.442 0.074 0.212 0.343 0.272 0.766 0.338 0.122 0.266 0.401
Femoral neck 0.893 0.844 0.363 0.483 0.713 0.806 0.845 0.344 0.479 0.753 0.338 0.405
Total hip 0.602 0.473 0.601 0.365 0.925 0.841 0.823 0.521 0.692 0.519 0.512 0.692
Test of population stratification in male-offspring nuclear families
L1-4 0.302 0.349 0.763 1.000 0.213 0.087 0.958 0.334 0.321 0.393 0.674 0.789
Femoral neck 0.524 0.453 0.845 0.832 0.364 0.473 0.948 0.405 0.325 0.389 0.435 0.299
Total hip 0.967 0.889 0.512 0.869 0.507 0.779 0.247 0.389 0.348 0.821 0.101 0.513
Test of total association in male-offspring nuclear families
L1-4 0.724 0.981 0.553 0.799 0.745 0.937 0.593 0.839 0.968 0.976 0.988 0.980
Femoral neck 0.810 0.814 0.499 0.621 0.544 0.703 0.989 0.558 0.687 0.958 0.679 0.986
Total hip 0.583 0.393 0.507 0.994 0.323 0.238 0.724 0.891 0.810 0.613 0.570 0.501
Test of within-family association in male-offspring nuclear families
L1-4 0.445 0.393 0.964 0.979 0.213 0.151 0.759 0.434 0.392 0.446 0.714 0.821
Femoral neck 0.633 0.426 0.618 0.990 0.266 0.409 0.960 0.324 0.301 0.432 0.379 0.344
Total hip 0.781 0.817 0.815 0.892 0.292 0.728 0.413 0.405 0.348 0.659 0.082 0.753
*p,0.05.
doi:10.1371/journal.pone.0028874.t004
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femoral neck and trochanter were 1.39%, 0.70%, 2.22% and
1.41%, respectively [33]. The long-term reproducibility of our
DXA data during the trial based on weekly repeated phantom
measurements was 99.55%[32]. Height and body weight were
measured using standardized equipment. Body mass Index (BMI)
was defined as weight/height
2 in kg/m
2.
SNP selection and genotyping
The selection of evaluated tagSNPs depended on the HapMap
database. In order to draw a reliable conclusion, the recruitment
criteria were essential: (1) minor allele frequency (MAF) .0.10; (2)
r
2=0.8; (3) tagSNPs in the exon region, exon-intron splice
conjunction, 59 flanking region or 39 untranslated region (UTR).
Hence, the only two tagSNPs in the exon region (rs4667591 in
exon 69 and rs2075252 in exon 66) and four tagSNPs in the intron
region (rs2389557, rs2544381, rs7600336 and rs10210408)
spanning the LRP2 gene were selected for the following association
study.
Genomic DNA was isolated from peripheral blood leukocytes
using the conventional phenol-chloroform extraction method.
Genotypes were identified by the TaqMan assay (Applied
Biosystems, Foster City, CA, USA) using the Applied Biosystems
SNP assay-by-design service according to the manufacturer’s
instructions. One allelic probe was labeled with fluorescent FAM
dye and the other with fluorescent VIC dye.
Haplotype and LD analysis
Haplotypes were constructed from the population genotypic
data by the algorithm of Stephens using Phase program version
2.0.2. The significance level for LD between the LRP2 gene
markers was assessed according to the observed haplotype and
allelic frequencies using Haploview version 3.2. The Lewontin’s D’
and LD coefficient r
2 between all pairs of biallelic loci were
examined.
Statistical analyses
Genotype frequencies were tested against Hardy-Weinberg
equilibrium by the x
2 test to estimate the population homogeneity
of the study subjects. To ensure unrelated individual samples, only
genotype data from the 1460 parents of the nuclear families were
used in the statistical analysis [31].
The quantitative transmission disequilibrium test (QTDT)
program, available at http://www.sph.umich.edu/csg/abecasis/
QTDT/, was used to determine population stratification, total
family association and within-family association between SNPs
and haplotypes and the BMD phenotypes in female- and male-
offspring families separately. This method [32,34,35] extends the
trio-based TDT to quantitative trait data and uses genotypic data
from available sibling and parents. Sex was not used as a covariate
during analysis because only healthy sons or daughters were
recruited in the study families and the effects of the parental
phenotypes were already excluded.
One-way ANOVA and general linear model-ANOVA (GLM-
ANOVA) were also employed to test the association between
genotypes and peak BMD in 330 unrelated adult daughters and
400 unrelated adult sons from the studied nuclear families.
Statistical analyses were performed using the SPSS package,
version 17.0 (SPSS, Chicago, IL, USA).
In all above-mentioned statistical analyses, BMD values were
previously adjusted by age, height and weight as covariates.
P,0.05 was considered significant for all analyses.
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